Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 18, 2021
VX-809 mitigates disease in a mouse model of autosomal dominant polycystic kidney disease bearing the R3277C human mutationMurali K Yanda, Liudmila Cebotaru
American Journal of Physiology. Renal Physiology|July 28, 2017
An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney diseaseMurali K Yanda, Qiangni Liu, Liudmila Cebotaru
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 7, 2023
Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse modelMurali K Yanda, Adi Zeidan, Liudmila Cebotaru
The Journal of Biological Chemistry|June 8, 2018
A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR correctorMurali K Yanda, Qiangni Liu, Liudmila Cebotaru
Cellular and Molecular Gastroenterology and Hepatology|July 30, 2021
Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney DiseaseMurali K Yanda, Vartika Tomar, Liudmila Cebotaru
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 12, 2019
A new role for heat shock factor 27 in the pathophysiology of <i>Clostridium difficile</i> toxin BMurali K Yanda, William B Guggino, Liudmila Cebotaru
The Journal of Biological Chemistry|October 2, 2019
Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney diseaseMurali K Yanda, Boyoung Cha, Cristina V Cebotaru, et al.
American Journal of Physiology. Cell Physiology|July 31, 2023
CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney diseaseMurali K Yanda, Cristian Ciobanu, William B Guggino, et al.
Human Gene Therapy|September 1, 2020
Transduction of Surface and Basal Cells in Rhesus Macaque Lung Following Repeat Dosing with AAV1CFTRWilliam B Guggino, Murali K Yanda, Cristina V Cebotaru, et al.
The Journal of Biological Chemistry|September 10, 2017
Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca<sup>2+</sup> in knock-out mouse models of polycystic kidney diseaseMurali K Yanda, Qiangni Liu, Valeriu Cebotaru, et al.
Pageof 2